GlassScriptPhysician profile
Peter F Lovato
NPI 1235577727
$162,018.84
in general payments reported to CMS, 2019-2025
37 companies · $41K in 2025
The $41K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,620 · 2020: $2,162 · 2021: $5,469 · 2022: $13K · 2023: $36K · 2024: $61K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $67K · Travel and Lodging: $20K · Consulting Fee: $15K · Food and Beverage: $15K · Honoraria: $9,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,460 · Education: $6,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $66,537.50 |
| Travel and Lodging | $20,324.61 |
| Consulting Fee | $14,950.00 |
| Food and Beverage | $14,685.68 |
| Honoraria | $9,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,460.20 |
| Education | $6,296.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $138,104.29 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Stryker Corporation | $9,170.96 | 2019-2025 | Citrefix, Infinity, Hoffmann |
| Fusion Orthopedics USA, LLC | $7,641.89 | 2023-2025 | Minilock, Lapilock |
| Surgenex LLC | $1,131.26 | 2025 | Renograft, Surmatrix, Ardeograft |
| Depuy Synthes Sales INC. | $682.10 | 2019-2025 | Hammerlock, Motoband, Fibergraft Bg Morsels |
| Treace Medical Concepts, INC. | $517.09 | 2023-2025 | |
| Osteomed LLC | $490.37 | 2019-2022 | |
| Medshape, INC. | $348.02 | 2019-2023 | Dynanail |
| Medela LLC | $312.58 | 2021-2023 | Invia Motion Endure |
| Paragon 28, INC. | $276.56 | 2019-2025 | Phantom Fibula Nail, Activcore Nail |
| Anika Therapeutics, INC. | $270.12 | 2024 | Sports Medicine, X-Twist, Anchors |
| Medtronic, INC. | $250.56 | 2021-2022 | |
| Biocomposites INC | $211.27 | 2019-2025 | Stimulan |
| Miach Orthopaedics, INC. | $183.28 | 2024 | |
| Aroa Biosurgery Incorporated | $175.22 | 2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Extremity Systems, LLC | $172.02 | 2019 | |
| Ossdsign USA Incorporated | $164.26 | 2024 | |
| Abbott Laboratories | $146.55 | 2022 | |
| Ortho Solutions INC | $143.73 | 2024 | |
| Biotissue Holdings INC. | $142.90 | 2020-2022 | |
| Biocompatibles, INC. | $138.84 | 2019 | |
| Acera Surgical, INC. | $137.47 | 2021-2022 | |
| Nevro Corp. | $128.99 | 2019-2022 | |
| Melinta Therapeutics, LLC | $125.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $124.96 | 2020-2021 | |
| Flower Orthopedics Coporation | $123.20 | 2025 | |
| Allergan, INC. | $122.58 | 2019 | |
| Bone Support INC. | $117.76 | 2025 | Ceramentbone Void Filler, Cerament G |
| Amniox Medical, INC. | $91.94 | 2020 | |
| Globus Medical, INC. | $89.70 | 2024 | Harvest |
| Acumed LLC | $86.45 | 2023 | Acumed, Osteomed |
| Amgen INC. | $46.80 | 2025 | Krystexxa |
| Wright Medical Technology, INC. | $35.83 | 2020 | |
| Axogen | $35.77 | 2021 | |
| Paratek Pharmaceuticals, INC. | $29.09 | 2019-2025 | Nuzyra |
| Misonix INC | $27.93 | 2021 | |
| Avita Medical Americas, LLC | $21.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lovato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.